| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716951 | Null | 0.0342636096654271 | -0.061980463 |
| NSC 726267 | Null | 0.0342636096654271 | 0.42794089 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0342636096654271 | -0.17733282 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0342636096654271 | 0.12605944 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0342636096654271 | -0.042915386 |
| NSC 733504 | Everolimus | 0.0342636096654271 | 0.3059044 |
| NSC 737231 | Null | 0.0342636096654271 | -0.11712894 |
| NSC 747461 | Null | 0.0342636096654271 | 0.47768378 |
| NSC 751152 | 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone | 0.0342636096654271 | -0.091377083 |
| NSC 84074 | Phosphonium, (3-bromopropyl)triphenyl- bromide | 0.0342636096654271 | 0.17407946 |